Last Updated on October 2, 2022
Introduction
• A multi-system disease
• Female to male ratio 3:1
• Peak incidence: 30 – 50 years old
• 2 types: (i) limited cutaneous systemic sclerosis, (ii) diffuse cutaneous systemic sclerosis
Pathogenesis
• Widespread vascular damage involving small arteries, arterioles, and capillaries, leading to arterial lesions & chronic ischaemia
• Vasoconstriction / vasospasm occurs
• Fibroblasts stimulated to cause fibrosis: Increased quantities of collagen, fibronectin and glycosaminoglycans → fibrosis in lower dermis of the skin & internal organs
1980 ACR Scleroderma Classification Criteria
- 1 major criterion OR ≥2 minor criteria
Major criterion
• Proximal cutaneous sclerosis / non-pitting skin thickening
=====
Notes:
– Usually the sclerosis / skin thickening is bilateral, symmetrical and almost always including sclerodactyly
Minor criteria
• Sclerodactyly
• Pitting scars of fingertips OR loss of substance of distal finger pad
• Bibasal pulmonary fibrosis
Modified Rodnan skin score (mRSS)
Components
• Face
• Anterior chest
• Abdomen
• Fingers (left & right)
• Hands (left & right)
• Forearms (left & right)
• Upper arms (left & right)
• Feet (left & right)
• Legs (left & right)
• Thighs (left & right)
Scores
mRSS =0 — “normal skin” where the examiner appreciates fine wrinkles but no skin thickness is present.
mRSS =1 — definite but “mild” skin thickness where the examiner can easily make skin folds between 2 fingers; fine wrinkles are acceptable.
mRSS =2 — “moderate” skin thickness with difficulty in making skin folds and no wrinkles.
mRSS =3 — “severe” skin thickness with inability to make skin folds between 2 examining fingers.
Significance
Worsening mRSS is associated with higher mortality, and both negative renal and cardiac outcomes
Reference
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431585/
Clinical Manifestation
1. Skin & face
- Tight & thickened skin over face, hands, feet
- Telangiectasia
- Perioral furrowing; microstomia
- Beaky nose
- Raynaud’s phenomenon
- Sclerodactyly
- Finger pulp atrophy
- Digital pitting scar
- Digital ulcer
2. Lungs
- Pulmonary fibrosis / interstitial lung disease
- Pulmonary hypertension
3. Heart
- Myocardial fibrosis
4. Gastrointestinal system
- Oesophagus: dysmotility / stricture / GERD
- Intestine: malabsorption, hypomotility, incontinence, pseudo-obstruction
5. Renal system
- Scleroderma renal crisis — severe HTN and worsening renal function
Clinical Features
History Taking / Symptoms
Presentation
• Raynaud’s phenomenon (most common presenting symptom)
• Dysphagia
Symptoms
• Raynaud’s phenomenon — e.g. fingers turning blue-black in cold water / washing dishes
• Skin tightness
• Joint pain / joint swelling
• Muscle weakness
• Weight loss / Anorexia
• Water brash / epigastric pain / heartburn / dysphagia
• Lethargy / reduced effort tolerance / orthopnoea / paroxysmal nocturnal dyspnoea / SOB / leg swelling
• Diarrhoea / steatorrhoea / constipation / abdominal pain
Relevant History
• Family history of autoimmune disease / systemic sclerosis
• Pregnancy history: How many pregnancy? How many miscarriage? How many live births? Mode of delivery for each pregnancy? How old are the children? Any antenatal complications?
Physical Examination
Face & chest
• Beaky nose
• Furrowing of mouth
• Microstomia
• Telangiectasia
Peripheries (fingers & hands)
• Digital ulcer
• Digital pitting scars
• Finger pulp atrophy
• Fixed flexion deformity
• Sclerodactyly / Thickened skin
CVS
• Parasternal heave
• Loud P2
Lungs
• Bibasal crepitations
Lower Limbs
• Proximal myopathy
• Leg ulcer
Others
• Blood pressure
Investigations
Bedside
• ECG
Blood investigations
• FBC
• Renal profile
• Rheumatoid factor
• Antinuclear antibody (ANA) screening
Other lab investigations
• Urine FEME
Imaging
• Chest X-ray
• Echocardiogram
• HRCT thorax
Other investigations
• OGDS
• Spirometry
Management
Raynaud’s phenomenon
• Avoid cold
• Vasodilators e.g. ACEI, ARB, calcium channel blocker
Pulmonary hypertension
• Vasodilator
Pulmonary fibrosis
• Immunosuppressants
Oesophageal symptoms
• Proton pump inhibitors (PPI) e.g. pantoprazole, omeprazole
Renal involvement / hypertension
• ACEI
Medications to be avoided
• ß-blockers
• High-dose corticosteroids e.g. >10 mg prednisolone daily